Sarah Kilpatrick is a Vice President and Head of Corporate Development with twenty years of experience in biopharma and consulting, specializing in M&A and asset management. They have held various leadership roles at Pfizer, including Vice President of Business Development and Corporate Development, overseeing significant projects in worldwide R&D and internal medicine. Prior to their tenure at Pfizer, they served as a Management Consultant at Mitchell Madison Group and as a Finance Associate at Pfizer. Sarah is currently pursuing an MBA at Stanford University Graduate School of Business and holds a BS from the California Institute of Technology.
This person is not in any teams
This person is not in any offices